University of Pennsylvania cell therapy spinoff raises $38M
November 08, 2018 at 11:10 AM EST
Cabaletta Bio has entered into two multiyear sponsored research agreements with Penn for the discovery and development of therapies to treat certain autoimmune diseases.
